US · Healthcare · Medical Care Facilities
EPS came in at 7.59 against a street estimate of 7.57 — a beat of 0.3%.
Analysts rate HCA Healthcare, Inc. a buy (15 buy, 9 hold, 1 sell out of 25) with an average price target of $453.38.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.17% |
| Vanguard Capital Management, LLC | 4.70% |
| Sanders Capital, LLC | 4.14% |
| State Street Corp | 3.48% |
| FMR Inc | 2.03% |
| Wellington Management Company LLP | 1.80% |
| Geode Capital Management, LLC | 1.71% |
| Arnhold & S. Bleichroeder Advisers, LLC | 1.50% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 | 2026-07-29 |
| Quarterly report · Q2 2026 | 2026-07-28 |
| Results announced · Q3 2026 | 2026-07-24 |
| Results announced · Q3 2026 | 2026-07-14 |
| Board / officer change · Q2 2026 | 2026-06-18 |
| Quarterly report · Q1 2026 | 2026-04-29 |
| Proxy statement · Q2 2026 | 2026-03-13 |
| Annual report FY2025 | 2026-02-10 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.78 / share ex-date Sep 16, 2026 · pay Sep 30, 2026 | 2026-09-16 |
| Dividend | $0.78 / share ex-date Jun 16, 2026 · pay Jun 30, 2026 | 2026-06-16 |
| Dividend | $0.78 / share ex-date Mar 17, 2026 · pay Mar 31, 2026 | 2026-03-17 |
| Dividend | $0.72 / share ex-date Dec 15, 2025 · pay Dec 29, 2025 | 2025-12-15 |
| Dividend | $0.72 / share ex-date Sep 16, 2025 · pay Sep 30, 2025 | 2025-09-16 |
| Announcement | Date |
|---|---|
| Updated full year guidance and second quarter 2026 financial results HCA Healthcare reported Q2 2026 results with mixed performance. Revenues grew 8.7% to $20.2 billion and diluted EPS increased 11.6% to $7.62, beating expectations. However, profitability gro | 2026-07-24 |
| Q2 2026 results previewed, full year 2026 guidance revised HCA Healthcare reported Q2 2026 results with mixed performance, prompting downward guidance revisions. Revenue reached $20.23 billion (up 8.7% YoY), and net income was $1.70 billion or $7.62 | 2026-07-14 |
| Fourth quarter 2025 results reported and 2026 guidance provided HCA Healthcare reported strong fourth quarter 2025 results with significant year-over-year growth. Revenues increased 6.7% to $19.5 billion, while net income jumped 30.6% to $1.9 billion. Ea | 2026-01-27 |
| Q3 2025 results reported and 2025 guidance raised HCA Healthcare reported strong third-quarter 2025 results and raised its full-year guidance. Key highlights: revenues grew 9.6% to $19.2 billion, net income surged 29.4% to $1.6 billion, and | 2025-10-24 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for HCA Healthcare, Inc. — free to start.
Google PlayApp StoreData updated 2026-08-05.